Eva Live Inc. (the “Company”) filed a Current Report on Form 8-K with the Securities and Exchange Commission on October 19, 2026. The filing details the execution of an Equity Purchase Agreement and the issuance of a warrant to Hudson Global Ventures, LLC. The Company also included an opinion from its legal counsel regarding the validity of its common stock shares.
The Company previously disclosed on September 23, 2026, that it entered into an Equity Purchase Agreement with Hudson Global Ventures, LLC. Under the terms of this agreement, Eva Live Inc. has the right, but not the obligation, to direct the Investor to purchase up to 5,000,000 shares of the Company’s common stock, par value $0.0001 per share. The aggregate purchase price for these shares, referred to as the “Put Shares,” is capped at $10,000,000.
In connection with the Purchase Agreement, the Company issued a Common Stock Purchase Warrant dated September 17, 2026. This warrant allows the Investor to purchase 275,000 shares of common stock. The warrant is exercisable for a period of five years, beginning after September 17, 2026, at an exercise price of $0.01 per share.
The issuance of the Put Shares and the Warrant Shares was registered pursuant to the Company’s shelf registration statement on Form S-3 (File No. 333-294416). This registration statement was filed with the Commission on March 18, 2026, and declared effective on March 24, 2026. Additionally, a prospectus supplement to the base prospectus forming a part of the registration statement was filed by the Company on October 19, 2026.
The filing includes an exhibit containing the opinion of Sichenzia Ross Ference Carmel LLP regarding the validity of the Common Stock shares issued to the Investor.
